Ion Channels as Therapeutic Targets: A Drug Discovery Perspective

详细信息    查看全文

• 作者：Sharan K. Bagal ; Alan D. Brown ; Peter J. Cox ; Kiyoyuki Omoto ; Robert M. Owen ; David C. Pryde ; Benjamin Sidders ; Sarah E. Skerratt ; Edward B. Stevens ; R. Ian Storer ; Nigel A. Swain
• 刊名：Journal of Medicinal Chemistry
• 出版年：2013
• 出版时间：February 14, 2013
• 年：2013
• 卷：56
• 期：3
• 页码：593-624
• 全文大小：1701K
• 年卷期：v.56,no.3(February 14, 2013)
• ISSN：1520-4804

文摘

Ion channels are membrane proteins expressed in almost all living cells. The sequencing of the human genome has identified more than 400 putative ion channels, but only a fraction of these have been cloned and functionally tested. The widespread tissue distribution of ion channels, coupled with the plethora of physiological consequences of their opening and closing, makes ion-channel-targeted drug discovery highly compelling. However, despite some important drugs in clinical use today, as a class, ion channels remain underexploited in drug discovery and many existing drugs are poorly selective with significant toxicities or suboptimal efficacy. This Perspective seeks to review the ion channel family, its structural and functional features, and the diseases that are known to be modulated by members of the family. In particular, we will explore the structure and properties of known ligands and consider the future prospects for drug discovery in this challenging but high potential area.